Role of folate in nonalcoholic fatty liver disease

Canadian Journal of Physiology and Pharmacology

Volumn 95, Issue 10, 2017, Pages 1141-1148

  Sid, Victoria ^a,b   Siow, Yaw L ^a,b,c   Karmin, O ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

Folate; Inflammation; Nonalcoholic fatty liver disease; Oxidative stress; Steatosis

Indexed keywords

FOLIC ACID; AUTACOID;

CARBOHYDRATE METABOLISM; DISEASE COURSE; FOLATE METABOLISM; HUMAN; INFLAMMATION; INTESTINE ABSORPTION; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG EFFECTS; ENERGY METABOLISM; FOLIC ACID DEFICIENCY; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; ENERGY METABOLISM; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; INFLAMMATION MEDIATORS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS;

EID: 85030097166     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2016-0681     Document Type: Review

References (115)

1. Adiels, M., Taskinen, M.R., Packard, C., Caslake, M.J., Soro-Paavonen, A., Westerbacka, J., et al. 2006. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia, 49(4): 755-765. doi:10.1007/s00125-005-0125-z.PMID:16463046.
2. Ahmed, M. 2015. Non-alcoholic fatty liver disease in 2015. World J. Hepatol. 7(11): 1450-1459. doi:10.4254/wjh.v7.i11.1450.PMID:26085906.
3. Argo, C.K., Northup, P.G., Al-Osaimi, A.M., and Caldwell, S.H. 2009. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J. Hepatol. 51(2): 371-379. doi:10.1016/j.jhep.2009.03.019.PMID:19501928.
4. Au-Yeung, K.K., Yip, J.C., Siow, Y.L., and O, K. 2006. Folic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophages. Can. J. Physiol. Pharmacol. 84(1): 141-147. doi:10.1139/Y05-136.PMID:16845898.
5. Bailey, R.L., Dodd, K.W., Gahche, J.J., Dwyer, J.T., McDowell, M.A., Yetley, E.A., et al. 2010. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am. J. Clin. Nutr. 91(1): 231-237. doi:10.3945/ajcn.2009.28427.PMID:19923379.
6. Bailey, S.W., and Ayling, J.E. 2009. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc. Natl. Acad. Sci. U.S.A. 106(36): 15424-15429. doi:10.1073/pnas.0902072106.PMID:19706381.
7. Barlowe, C.K., and Appling, D.R. 1988. In vitro evidence for the involvement of mitochondrial folate metabolism in the supply of cytoplasmic one-carbon units. Biofactors, 1(2): 171-176. PMID:2475123.
8. Bird, J.K., Ronnenberg, A.G., Choi, S.W., Du, F., Mason, J.B., and Liu, Z. 2015. Obesity is associated with increased red blood cell folate despite lower dietary intakes and serum concentrations. J. Nutr. 145(1): 79-86. doi:10.3945/jn.114.199117.PMID:25527662.
9. Birkenfeld, A.L., and Shulman, G.I. 2014. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology, 59(2): 713-723. doi:10.1002/hep.26672.PMID:23929732.
10. Blom, H.J., Shaw, G.M., den Heijer, M., and Finnell, R.H. 2006. Neural tube defects and folate: case far from closed. Nat. Rev. Neurosci. 7(9): 724-731. doi:10.1038/nrn1986.PMID:16924261.
11. Boushey, C.J., Beresford, S.A., Omenn, G.S., and Motulsky, A.G. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA, 274(13): 1049-1057. PMID:7563456.
12. Brattström, L., Wilcken, D.E., Ohrvik, J., and Brudin, L. 1998. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation, 98(23): 2520-2526. doi:10.1161/01.CIR.98.23.2520.PMID:9843457.
13. Brunt, E.M., and Tiniakos, D.G. 2010. Histopathology of nonalcoholic fatty liver disease. World J. Gastroenterol. 16(42): 5286-5296. doi:10.3748/wjg.v16.i42.5286.PMID:21072891.
14. Burda, P., Schäfer, A., Suormala, T., Rummel, T., Bürer, C., Heuberger, D., et al. 2015. Insights into severe 5,10-methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients. Hum. Mutat. 36(6): 611-621. doi:10.1002/humu.22779.PMID:25736335.
15. Buzzetti, E., Pinzani, M., and Tsochatzis, E.A. 2016. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism, 65(8): 1038-1048. doi:10.1016/j.metabol.2015.12.012.PMID:26823198.
16. Camilo, E., Zimmerman, J., Mason, J.B., Golner, B., Russell, R., Selhub, J., and Rosenberg, I.H. 1996. Folate synthesized by bacteria in the human upper small intestine is assimilated by the host. Gastroenterology, 110(4): 991-998. doi:10.1053/gast.1996.v110.pm8613033.PMID:8613033.
17. Cario, H., Smith, D.E., Blom, H., Blau, N., Bode, H., Holzmann, K., et al. 2011. Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am. J. Hum. Genet. 88(2): 226-231. doi:10.1016/j.ajhg.2011.01.007.PMID:21310277.
18. CDC. 2010. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morb. Mortal. Wkly. Rep. 59(31): 980-984. PMID:20703205.
19. Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., et al. 2012. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 55(6): 2005-2023. doi:10.1002/hep.25762.PMID:22488764.
20. Champier, J., Claustrat, F., Nazaret, N., Fèvre Montange, M., and Claustrat, B. 2012. Folate depletion changes gene expression of fatty acid metabolism, DNA synthesis, and circadian cycle in male mice. Nutr. Res. 32(2): 124-132. doi:10.1016/j.nutres.2011.12.012.PMID:22348461.
21. Chou, Y.F., Yu, C.C., and Huang, R.F. 2007. Changes in mitochondrial DNA deletion, content, and biogenesis in folate-deficient tissues of young rats depend on mitochondrial folate and oxidative DNA injuries. J. Nutr. 137(9): 2036-2042. PMID:17709439.
22. Christensen, K.E., Wu, Q., Wang, X., Deng, L., Caudill, M.A., and Rozen, R. 2010. Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism. J. Nutr. 140(10): 1736-1741. doi:10.3945/jn.110.124917.PMID:20724492.
23. Clarke, R. 2000. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials. Indian Heart J. 52: S59-S64. PMID: 11339443.
24. Cohen, J.C., Horton, J.D., and Hobbs, H.H. 2011. Human fatty liver disease: old questions and new insights. Science, 332(6037): 1519-1523. doi:10.1126/science.1204265.PMID:21700865.
25. da Silva, R.P., Kelly, K.B., Al Rajabi, A., and Jacobs, R.L. 2014. Novel insights on interactions between folate and lipid metabolism. Biofactors, 40(3): 277-283. doi:10.1002/biof.1154.PMID:24353111.
26. Day, C.P. 2006. From fat to inflammation. Gastroenterology, 130(1): 207-210. doi:10.1053/j.gastro.2005.11.017.PMID:16401483.
27. Day, C.P., and James, O.F. 1998. Steatohepatitis: a tale of two “hits”? Gastroenterology, 114(4): 842-845. doi:10.1016/S0016-5085(98)70599-2.PMID:9547102.
28. De Wals, P., Tairou, F., Van Allen, M.I., Uh, S.H., Lowry, R.B., Sibbald, B., et al. 2007. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 357(2): 135-142. doi:10.1056/NEJMoa067103.PMID:17625125.
29. Dhonukshe-Rutten, R.A., de Vries, J.H., de Bree, A., van der Put, N., van Staveren, W.A., and de Groot, L.C. 2009. Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. Eur. J. Clin. Nutr. 63(1): 18-30. doi:10.1038/sj.ejcn.1602897.PMID:17851461.
30. Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., Jessurun, J., Boldt, M.D., and Parks, E.J. 2005. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115(5): 1343-1351. doi:10.1172/JCI23621.PMID:15864352.
31. Elsharkawy, A.M., and Mann, D.A. 2007. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology, 46(2): 590-597. doi:10.1002/hep.21802.PMID:17661407.
32. Fabbrini, E., Mohammed, B.S., Magkos, F., Korenblat, K.M., Patterson, B.W., and Klein, S. 2008. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology, 134(2): 424-431. doi:10.1053/j.gastro.2007.11.038.PMID:18242210.
33. Fabbrini, E., Sullivan, S., and Klein, S. 2010. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology, 51(2): 679-689. doi:10.1002/hep.23280.PMID:20041406.
34. Fan, J., Ye, J., Kamphorst, J.J., Shlomi, T., Thompson, C.B., and Rabinowitz, J.D. 2014. Quantitative flux analysis reveals folate-dependent NADPH production. Nature, 510(7504): 298-302. doi:10.1038/nature13236.PMID:24805240.
35. Farrell, G.C., and Larter, C.Z. 2006. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology, 43: S99-S112. doi:10.1002/hep.20973.PMID:16447287.
36. Fast, D.G., and Vance, D.E. 1995. Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion. Biochim. Biophys. Acta, Lipids Lipid Metab. 1258(2): 159-168. doi:10.1016/0005-2760(95)00116-T.PMID:7548179.
37. García-Casal, M.N., Osorio, C., Landaeta, M., Leets, I., Matus, P., Fazzino, F., and Marcos, E. 2005. High prevalence of folic acid and vitamin B12 deficiencies in infants, children, adolescents and pregnant women in Venezuela. Eur. J. Clin. Nutr. 59(9): 1064-1070. doi:10.1038/sj.ejcn.1602212.PMID:16015269.
38. Gliszczyńska-Świgło, A., and Muzolf, M. 2007. pH-Dependent radical scavenging activity of folates. J. Agric. Food Chem. 55(20): 8237-8242. doi:10.1021/jf070986x.PMID:17848080.
39. Halliwell, B., and Whiteman, M. 2004. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142(2): 231-255. doi:10.1038/sj.bjp.0705776.PMID:15155533.
40. Hardie, D.G., Ross, F.A., and Hawley, S.A. 2012. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13(4): 251-262. doi:10.1038/nrm3311.PMID:22436748.
41. Hardwick, R.N., Fisher, C.D., Canet, M.J., Lake, A.D., and Cherrington, N.J. 2010. Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab. Dispos. 38(12): 2293-2301. doi:10.1124/dmd.110.035006.PMID:20805291.
42. Henning, S.M., Swendseid, M.E., Ivandic, B.T., and Liao, F. 1997. Vitamins C, E and A and heme oxygenase in rats fed methyl/folate-deficient diets. Free Radical Biol. Med. 23(6): 936-942. doi:10.1016/S0891-5849(97)00097-X.
43. Herbig, K., Chiang, E.P., Lee, L.R., Hills, J., Shane, B., and Stover, P.J. 2002. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J. Biol. Chem. 277(41): 38381-38389. doi:10.1074/jbc.M205000200.PMID:12161434.
44. Hirsch, S., Poniachick, J., Avendaño, M., Csendes, A., Burdiles, P., Smok, G., et al. 2005. Serum folate and homocysteine levels in obese females with nonalcoholic fatty liver. Nutrition, 21(2): 137-141. doi:10.1016/j.nut.2004.03.022.PMID:15723740.
45. Homocysteine Studies Collaboration. 2002. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 288(16): 2015-2022. doi:10.1001/jama.288.16.2015.PMID:12387654.
46. Horne, D.W., Reed, K.A., Hoefs, J., and Said, H.M. 1993. 5-Methyltetrahydrofolate transport in basolateral membrane vesicles from human liver. Am. J. Clin. Nutr. 58(1): 80-84. PMID:8317394.
47. Hu, J., Wang, B., and Sahyoun, N.R. 2016. Application of the key events doseresponse framework to folate metabolism. Crit. Rev. Food Sci. Nutr. 56(8): 1325-1333. doi:10.1080/10408398.2013.807221.PMID:25674817.
48. Huang, R.F., Hsu, Y.C., Lin, H.L., and Yang, F.L. 2001. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J. Nutr. 131(1): 33-38. PMID:11208935.
49. Hwang, S.Y., Siow, Y.L., Au-Yeung, K.K., House, J., and O, K. 2011. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney. Am. J. Physiol. Renal Physiol. 300(1): F189-F198. doi:10.1152/ajprenal.00272.2010.PMID:20980407.
50. IDF. 2005. The IDF consensus worldwide definition of the metabolic syndrome. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. 1998. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. The National Academies Press, Washington, D.C.
51. Ito, T., and Ikeda, U. 2003. Inflammatory cytokines and cardiovascular disease. Curr. Drug Targets: Inflammation Allergy, 2(3): 257-265. doi:10.2174/1568010033484106.PMID:14561160.
52. Iyer, R., and Tomar, S.K. 2009. Folate: a functional food constituent. J. Food Sci. 74(9): R114-R122. doi:10.1111/j.1750-3841.2009.01359.x.PMID:20492126.
53. Joshi, R., Adhikari, S., Patro, B.S., Chattopadhyay, S., and Mukherjee, T. 2001. Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radical Biol. Med. 30(12): 1390-1399. doi:10.1016/S0891-5849(01)00543-3.
54. Kaludercic, N., Deshwal, S., and Di Lisa, F. 2014. Reactive oxygen species and redox compartmentalization. Front. Physiol. 5: 285. doi:10.3389/fphys.2014.00285.PMID:25161621.
55. Kim, Y.I., Miller, J.W., da Costa, K.A., Nadeau, M., Smith, D., Selhub, J., et al. 1994. Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. J. Nutr. 124(11): 2197-2203. PMID:7965204.
56. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., et al. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 41(6): 1313-1321. doi:10.1002/hep.20701.PMID:15915461.
57. Kohjima, M., Enjoji, M., Higuchi, N., Kato, M., Kotoh, K., Yoshimoto, T., et al. 2007. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 20(3): 351-358. PMID:17671740.
58. Kolb, A.F., and Petrie, L. 2013. Folate deficiency enhances the inflammatory response of macrophages. Mol. Immunol. 54(2): 164-172. doi:10.1016/j.molimm.2012.11.012.PMID:23280395.
59. Lam, T.Y., Seto, S.W., Au, A.L., Poon, C.C., Li, R.W., Lam, H.Y., et al. 2009. Folic acid supplementation modifies beta-adrenoceptor-mediated in vitro lipolysis of obese/diabetic (+db/+db) mice. Exp. Biol. Med. 234(9): 1047-1055. doi:10.3181/0902-RM-44.
60. Larter, C.Z., and Yeh, M.M. 2008. Animal models of NASH: getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 23(11): 1635-1648. doi:10.1111/j.1440-1746.2008.05543.x.PMID:18752564.
61. Li, Z., and Vance, D.E. 2008. Phosphatidylcholine and choline homeostasis. J. Lipid Res. 49(6): 1187-1194. doi:10.1194/jlr.R700019-JLR200.PMID:18204095.
62. Loguercio, C., De Simone, T., D’Auria, M.V., de Sio, I., Federico, A., Tuccillo, C., et al. 2004. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig. Liver Dis. 36(6): 398-405. doi:10.1016/S1590-8658(04)00094-5.PMID:15248380.
63. Lonn, E., Yusuf, S., Arnold, M.J., Sheridan, P., Pogue, J., Micks, M., et al. 2006. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354(15): 1567-1577. doi:10.1056/NEJMoa060900.PMID:16531613.
64. Lucock, M. 2000. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 71(1-2): 121-138. doi:10.1006/mgme.2000.3027.PMID:11001804.
65. Mahabir, S., Ettinger, S., Johnson, L., Baer, D.J., Clevidence, B.A., Hartman, T.J., and Taylor, P.R. 2008. Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur. J. Clin. Nutr. 62(5): 644-650. doi:10.1038/sj.ejcn.1602771.PMID:17457338.
66. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., et al. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 50(8): 1844-1850. doi:10.2337/diabetes.50.8.1844.PMID:11473047.
67. McLaren, J.E., Michael, D.R., Ashlin, T.G., and Ramji, D.P. 2011. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. Prog. Lipid Res. 50(4): 331-347. doi:10.1016/j.plipres.2011.04.002.PMID:21601592.
68. McNeil, C.J., Hay, S.M., Rucklidge, G.J., Reid, M., Duncan, G., Maloney, C.A., and Rees, W.D. 2008. Disruption of lipid metabolism in the liver of the pregnant rat fed folate-deficient and methyl donor-deficient diets. Br. J. Nutr. 99(2): 262-271. doi:10.1017/S0007114507798999.PMID:17697402.
69. Medici, V., and Halsted, C.H. 2013. Folate, alcohol, and liver disease. Mol. Nutr. Food Res. 57(4): 596-606. doi:10.1002/mnfr.201200077.PMID:23136133.
70. Miranda, T.B., and Jones, P.A. 2007. DNA methylation: the nuts and bolts of repression. J. Cell. Physiol. 213(2): 384-390. doi:10.1002/jcp.21224.PMID:17708532.
71. Mojtabai, R. 2004. Body mass index and serum folate in childbearing age women. Eur. J. Epidemiol. 19(11): 1029-1036. doi:10.1007/s10654-004-2253-z.PMID:15648596.
72. Musso, G., Gambino, R., and Cassader, M. 2009. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 48(1): 1-26. doi:10.1016/j.plipres.2008.08.001.PMID:18824034.
73. Nilsson, E., Matte, A., Perfilyev, A., de Mello, V.D., Käkelä, P., Pihlajamäki, J., and Ling, C. 2015. Epigenetic alterations in human liver from subjects with type 2 diabetes in parallel with reduced folate levels. J. Clin. Endocrinol. Metab. 100(11): E1491-E1501. doi:10.1210/jc.2015-3204.PMID:26418287.
74. Noga, A.A., and Vance, D.E. 2003. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J. Biol. Chem. 278(24): 21851-21859. doi:10.1074/jbc.M301982200.PMID:12668679.
75. Noureddin, M., Mato, J.M., and Lu, S.C. 2015. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Exp. Biol. Med. 240(6): 809-820. doi:10.1177/1535370215579161.
76. Perry, J. 1971. Folate analogues in normal mixed diets. Br. J. Haematol. 21(4): 435-441. doi:10.1111/j.1365-2141.1971.tb02704.x.PMID:5122667.
77. Pietrzik, K., Bailey, L., and Shane, B. 2010. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet. 49(8): 535-548. doi:10.2165/11532990-000000000-00000.PMID:20608755.
78. Pike, S.T., Rajendra, R., Artzt, K., and Appling, D.R. 2010. Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos. J. Biol. Chem. 285(7): 4612-4620. doi:10.1074/jbc.M109.079855.PMID:19948730.
79. Pu, P., Gao, D.M., Mohamed, S., Chen, J., Zhang, J., Zhou, X.Y., et al. 2012. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch. Biochem. Biophys. 518(1): 61-70. doi:10.1016/j.abb.2011.11.026.PMID:22198281.
80. Qiu, A., Jansen, M., Sakaris, A., Min, S.H., Chattopadhyay, S., Tsai, E., et al. 2006. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell, 127(5): 917-928. doi:10.1016/j.cell.2006.09.041.PMID:17129779.
81. Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., and Younossi, Z.M. 2009. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 7(2): 234-238. doi:10.1016/j.cgh.2008.11.005.PMID:19049831.
82. Raghunathan, K., Schmitz, J.C., and Priest, D.G. 1997. Disposition of leucovorin and its metabolites in dietary folic acid-deplete mice-comparison between tumor, liver, and plasma. Cancer Chemother. Pharmacol. 40(2): 126-130. doi:10.1007/s002800050636.PMID:9182833.
83. Rolo, A.P., Teodoro, J.S., and Palmeira, C.M. 2012. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biol. Med. 52(1): 59-69. doi:10.1016/j.freeradbiomed.2011.10.003.
84. Rong, N., Selhub, J., Goldin, B.R., and Rosenberg, I.H. 1991. Bacterially synthesized folate in rat large intestine is incorporated into host tissue folyl polyglutamates. J. Nutr. 121(12): 1955-1959. PMID:1941259.
85. Saltiel, A.R., and Kahn, C.R. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414(6865): 799-806. doi:10.1038/414799a.PMID:11742412.
86. Sanyal, A.J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W.B., Contos, M.J., Sterling, R.K., et al. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 120(5): 1183-1192. doi:10.1053/gast.2001.23256.PMID:11266382.
87. Sarna, L.K., Wu, N., Wang, P., Hwang, S.Y., Siow, Y.L., and O, K. 2012. Folic acid supplementation attenuates high fat diet induced hepatic oxidative stress via regulation of NADPH oxidase. Can. J. Physiol. Pharmacol. 90(2): 155-165. doi:10.1139/y11-124.PMID:22309437.
88. Sawyer, D.E., and Van Houten, B. 1999. Repair of DNA damage in mitochondria. Mutat. Res. 434(3): 161-176. doi:10.1016/S0921-8777(99)00027-0.PMID:10486590.
89. Schuppan, D., and Schattenberg, J.M. 2013. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J. Gastroenterol. Hepatol. 28(S1): 68-76. doi:10.1111/jgh.12212.PMID:23855299.
90. Sehayek, E., Wang, R., Ono, J.G., Zinchuk, V.S., Duncan, E.M., Shefer, S., et al. 2003. Localization of the PE methylation pathway and SR-BI to the canalicular membrane: evidence for apical PC biosynthesis that may promote biliary excretion of phospholipid and cholesterol. J. Lipid Res. 44(9): 1605-1613. doi:10.1194/jlr.M200488-JLR200.PMID:12810817.
91. Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., and Wakasa, K. 2002. In situ detection of lipid peroxidation and oxidative DNA damage in nonalcoholic fatty liver diseases. J. Hepatol. 37(1): 56-62. doi:10.1016/S0168-8278(02)00073-9.PMID:12076862.
92. Shafizadeh, T.B., and Halsted, C.H. 2007. gamma-Glutamyl hydrolase, not glutamate carboxypeptidase II, hydrolyzes dietary folate in rat small intestine. J. Nutr. 137(5): 1149-1153. PMID:17449573.
93. Shin, Y.S., Chan, C., Vidal, A.J., Brody, T., and Stokstad, E.L. 1976. Subcellular localization of gamma-glutamyl carboxypeptidase and of folates. Biochim. Biophys. Acta, Gen. Subj. 444(3): 794-801. doi:10.1016/0304-4165(76)90326-3.PMID:186108.
94. Sid, V., Wu, N., Sarna, L.K., Siow, Y.L., House, J.D., and O, K. 2015. Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309(10): R1215-R1225. doi:10.1152/ajpregu.00260.2015.PMID:26400185.
95. Solini, A., Santini, E., and Ferrannini, E. 2006. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int. J. Obes. Relat. Metab. Disord. 30(8): 1197-1202. doi:10.1038/sj.ijo.0803265.
96. Steinberg, S.E., Campbell, C.L., and Hillman, R.S. 1979. Kinetics of the normal folate enterohepatic cycle. J. Clin. Invest. 64(1): 83-88. doi:10.1172/JCI109467.PMID:447863.
97. Stover, P.J. 2004. Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 62: S3-S12. doi:10.1111/j.1753-4887.2004.tb00070.x.
98. Stover, P.J., and Field, M.S. 2011. Trafficking of intracellular folates. Adv. Nutr. 2(4): 325-331. doi:10.3945/an.111.000596.PMID:22332074.
99. Sutti, S., Jindal, A., Locatelli, I., Vacchiano, M., Gigliotti, L., Bozzola, C., and Albano, E. 2014. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology, 59(3): 886-897. doi:10.1002/hep.26749.PMID:24115128.
100. Takahashi, Y., Soejima, Y., and Fukusato, T. 2012. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 18(19): 2300-2308. doi:10.3748/wjg.v18.i19.2300.PMID:22654421.
101. Tibbetts, A.S., and Appling, D.R. 2010. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30: 57-81. doi:10.1146/annurev.nutr.012809.104810.PMID:20645850.
102. Tilg, H., and Moschen, A.R. 2010. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology, 52(5): 1836-1846. doi:10.1002/hep.24001.PMID:21038418.
103. Updegraff, T.A., and Neufeld, N.J. 1981. Protein, iron, and folate status of patients prior to and following surgery for morbid obesity. J. Am. Diet. Assoc. 78(2): 135-140. PMID:7217567.
104. Utzschneider, K.M., and Kahn, S.E. 2006. The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 91(12): 4753-4761. doi:10.1210/jc.2006-0587.PMID:16968800.
105. Videla, L.A., Rodrigo, R., Orellana, M., Fernandez, V., Tapia, G., Quiñones, L., et al. 2004. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. 106(3): 261-268. doi:10.1042/CS20030285.PMID:14556645.
106. Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., et al. 2005. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology, 42(2): 473-480. doi:10.1002/hep.20781.PMID:15981216.
107. Visentin, M., Diop-Bove, N., Zhao, R., and Goldman, I.D. 2014. The intestinal absorption of folates. Annu. Rev. Physiol. 76: 251-274. doi:10.1146/annurevphysiol-020911-153251.PMID:24512081.
108. Wald, D.S., Law, M., and Morris, J.K. 2002. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 325(7374): 1202. doi:10.1136/bmj.325.7374.1202.PMID:12446535.
109. Wang, G., Dai, J., Mao, J., Zeng, X., Yang, X., and Wang, X. 2005. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis, 179(2): 395-402. doi:10.1016/j.atherosclerosis.2004.10.033.PMID:15777559.
110. WHO. 2016. http://www.who.int/mediacentre/factsheets/fs311/en/.
111. Woo, C.W., Prathapasinghe, G.A., Siow, Y.L., and O, K. 2006. Hyperhomocysteinemia induces liver injury in rat: protective effect of folic acid supplementation. Biochim. Biophys. Acta, Mol. Basis Dis. 1762(7): 656-665. doi:10.1016/j.bbadis.2006.05.012.PMID:16837172.
112. Wright, A.J., Dainty, J.R., and Finglas, P.M. 2007. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br. J. Nutr. 98(4): 667-675. doi:10.1017/S0007114507777140.PMID:17617936.
113. Zhao, R., Matherly, L.H., and Goldman, I.D. 2009. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev. Mol. Med. 11: e4. doi:10.1017/S1462399409000969.PMID:19173758.
114. Zhao, R., Diop-Bove, N., Visentin, M., and Goldman, I.D. 2011. Mechanisms of membrane transport of folates into cells and across epithelia. Annu. Rev. Nutr. 31: 177-201. doi:10.1146/annurev-nutr-072610-145133.PMID:21568705.
115. Zhao, Y., Su, B., Jacobs, R.L., Kennedy, B., Francis, G.A., Waddington, E., et al. 2009. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice. Arterioscler., Thromb., Vasc. Biol. 29(9): 1349-1355. doi:10.1161/ATVBAHA.109.188672.PMID:19520976.